BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21907272)

  • 1. A transferable sucrose utilization approach for non-sucrose-utilizing Escherichia coli strains.
    Bruschi M; Boyes SJ; Sugiarto H; Nielsen LK; Vickers CE
    Biotechnol Adv; 2012; 30(5):1001-10. PubMed ID: 21907272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of sucrose-utilizing Escherichia coli K-12 strain by cloning β-fructofuranosidases and its application for L-threonine production.
    Lee JW; Choi S; Park JH; Vickers CE; Nielsen LK; Lee SY
    Appl Microbiol Biotechnol; 2010 Oct; 88(4):905-13. PubMed ID: 20711572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular control of sucrose utilization in Escherichia coli W, an efficient sucrose-utilizing strain.
    Sabri S; Nielsen LK; Vickers CE
    Appl Environ Microbiol; 2013 Jan; 79(2):478-87. PubMed ID: 23124236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of cscR in Escherichia coli W improves growth and poly-3-hydroxybutyrate (PHB) production from sucrose in fed batch culture.
    Arifin Y; Sabri S; Sugiarto H; Krömer JO; Vickers CE; Nielsen LK
    J Biotechnol; 2011 Dec; 156(4):275-8. PubMed ID: 21782859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative reaction engineering studies for succinic acid production from sucrose by metabolically engineered Escherichia coli in fed-batch-operated stirred tank bioreactors.
    Hoefel T; Faust G; Reinecke L; Rudinger N; Weuster-Botz D
    Biotechnol J; 2012 Oct; 7(10):1277-87. PubMed ID: 22588847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli W shows fast, highly oxidative sucrose metabolism and low acetate formation.
    Arifin Y; Archer C; Lim S; Quek LE; Sugiarto H; Marcellin E; Vickers CE; Krömer JO; Nielsen LK
    Appl Microbiol Biotechnol; 2014 Nov; 98(21):9033-44. PubMed ID: 25125039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphotransferase system-dependent sucrose utilization regulon in enteropathogenic Escherichia coli strains is located in a variable chromosomal region containing iap sequences.
    Treviño-Quintanilla LG; Escalante A; Caro AD; Martínez A; González R; Puente JL; Bolívar F; Gosset G
    J Mol Microbiol Biotechnol; 2007; 13(1-3):117-25. PubMed ID: 17693719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of succinic acid from sucrose and sugarcane molasses by metabolically engineered Escherichia coli.
    Chan S; Kanchanatawee S; Jantama K
    Bioresour Technol; 2012 Jan; 103(1):329-36. PubMed ID: 22023966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate production from sucrose by metabolic engineered Escherichia coli strains under aerobic conditions.
    Wang J; Zhu J; Bennett GN; San KY
    Biotechnol Prog; 2011; 27(5):1242-7. PubMed ID: 21735558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, sequencing, and expression of cscA invertase from Escherichia coli B-62.
    Sahin-Tóth M; Lengyel Z; Tsunekawa H
    Can J Microbiol; 1999 May; 45(5):418-22. PubMed ID: 10446718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an E. coli platform strain for improved sucrose utilization using adaptive laboratory evolution.
    Mohamed ET; Mundhada H; Landberg J; Cann I; Mackie RI; Nielsen AT; Herrgård MJ; Feist AM
    Microb Cell Fact; 2019 Jun; 18(1):116. PubMed ID: 31255177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random Chromosomal Integration and Screening Yields
    Carruthers DN; Saleski TE; Scholz SA; Lin XN
    ACS Synth Biol; 2020 Dec; 9(12):3311-3321. PubMed ID: 33236893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fermentation of 10% (w/v) sugar to D: (-)-lactate by engineered Escherichia coli B.
    Zhou S; Yomano LP; Shanmugam KT; Ingram LO
    Biotechnol Lett; 2005 Dec; 27(23-24):1891-6. PubMed ID: 16328986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristic of saccharose fermentation by pathogenic Escherichia coli strains--phenotypic and genotypic elements].
    Skwark M; Czyzewska I
    Med Dosw Mikrobiol; 2003; 55(3):219-24. PubMed ID: 14702663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of tyrosine from sucrose or glucose achieved by rapid genetic changes to phenylalanine-producing Escherichia coli strains.
    Olson MM; Templeton LJ; Suh W; Youderian P; Sariaslani FS; Gatenby AA; Van Dyk TK
    Appl Microbiol Biotechnol; 2007 Apr; 74(5):1031-40. PubMed ID: 17216463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental evolution of an essential Bacillus gene in an E. coli host.
    Larios-Sanz M; Travisano M
    Methods Mol Biol; 2009; 532():269-87. PubMed ID: 19271191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hemoglobins to enhance microaerobic growth and substrate utilization in Escherichia coli.
    Bollinger CJ; Bailey JE; Kallio PT
    Biotechnol Prog; 2001; 17(5):798-808. PubMed ID: 11587567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient free fatty acid production in engineered Escherichia coli strains using soybean oligosaccharides as feedstock.
    Wang D; Wu H; Thakker C; Beyersdorf J; Bennett GN; San KY
    Biotechnol Prog; 2015; 31(3):686-94. PubMed ID: 25919701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of H2 from sucrose by Escherichia coli strains carrying the pUR400 plasmid, which encodes invertase activity.
    Penfold DW; Macaskie LE
    Biotechnol Lett; 2004 Dec; 26(24):1879-83. PubMed ID: 15672232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of a sucrose utilization system in Escherichia coli K-12 derivatives and its application to industry.
    Tsunekawa H; Azuma S; Okabe M; Okamoto R; Aiba S
    Appl Environ Microbiol; 1992 Jun; 58(6):2081-8. PubMed ID: 1622287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.